Valeant denies bypassing eye-device maker Iconlabs in M&A bid for lens tech

Fierce Pharma ------- After a disastrous two years for Valeant, the company faces a lawsuit alleging it “engaged in willful ignorance” to bypass a would-be partner and acquire intraocular lens technology from a third-party licensee. But Valeant has hit back with its own counterclaim. California’s Iconlabs alleges that the ailing drugmaker's Bausch & Lomb unit received two of Icon’s lenses for testing back in 2011, but later terminated their contract, saying it wasn’t interested in purchasing the technology. But B&L's subsidiary in Turkey pursued the technology through a local company that had licensed it, according to the lawsuit. To learn more click on the picture below to read the article.